Clinical Trials Logo

Clinical Trial Summary

The LipiFlow System (TearScience, Morrisville, NC) is an in-office FDA approved treatment for meibomian gland dysfunction. It relieves meibomian gland obstruction through the use of heat and pulsatile pressure. A recent study has observed that a single treatment with the LipiFlow system can decrease dry eye symptoms and objective findings of meibomian gland dysfunction for 1 year. We aim to see if the Lipiflow System will be beneficial in patients with Parkinsons disease who may have difficulty performing normal meibomian gland dysfunction treatment.


Clinical Trial Description

Objectives To determine whether a single treatment with thermal pulsation relieves dry eye symptoms (primary objective) and improves objective findings of meibomian gland dysfunction in patients with Parkinsons disease.

Methods and Measures

Design

- Randomized, controlled trial

- Patient eyes will be randomized to either receive a single thermal pulsation treatment the FDA-approved Lipiflow thermal pulsation system or to use traditional eyelid hygiene or to use traditional eyelid hygiene ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02894658
Study type Interventional
Source Wake Forest University Health Sciences
Contact
Status Suspended
Phase N/A
Start date August 2016
Completion date January 2020

See also
  Status Clinical Trial Phase
Terminated NCT02596919 - Fast Infrared Meibography (Photography) N/A
Completed NCT01207752 - The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction N/A
Completed NCT02256969 - Intraductal Meibomian Gland Probing Trial Phase 4
Recruiting NCT03318874 - Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction Phase 4
Not yet recruiting NCT02943382 - Fingerprick Autologous Blood (FAB) in Mebomian Gland Dysfunction (MGD) N/A
Recruiting NCT02618304 - Changes of Tear-film Lipid Layer Thickness and Ocular Aberration After Treatment of Meibomian Gland Dysfunction N/A
Completed NCT01942642 - Evaluation of Dry Eye and Meibomian Gland Dysfunction After Cataract Surgery N/A
Completed NCT01600625 - Effects of Minocycline on Cytokine Levels in Severe Meibomian Gland Dysfunction N/A
Terminated NCT02975557 - Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD) Phase 1/Phase 2
Completed NCT02952079 - Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis N/A
Completed NCT01870180 - EyeBag Effectiveness in Meibomian Gland Dysfunction N/A
Completed NCT00705510 - Efficacy of 0.05 % Cyclosporine Ophthalmic Emulsion Compare With Tear in Meibomian Gland Dysfunction Phase 4
Recruiting NCT03060005 - Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ? N/A
Not yet recruiting NCT03265652 - IPL and MGX Versus MGX Alone in the Treatment of Dry Eye Disease Secondary to MGD N/A
Not yet recruiting NCT03291704 - Investigating the Effect of At Home Thermal Therapy on Dry Eye Patients With Meibomian Gland Dysfunction N/A
Withdrawn NCT01797107 - Study to Determine the Effect of Azasite on Corneal Surface Irregularity Phase 2
Completed NCT01819194 - Contact Lens Comfort Relative to Meibomian Gland Status N/A
Completed NCT01552174 - Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice N/A
Withdrawn NCT01917539 - Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye Syndrome N/A
Completed NCT01382108 - Meibography and Tear Scan Using the Oculus Keratograph 4 N/A